The antibody from Chicago-based Immunartes is designed to neutralize the immune-evasive mechanisms of Staphylococcus aureus.

Background: The rise in community-onset methicillin-resistant Staphylococcus aureus (MRSA) infections potentially complicates the empiric management of cellulitis. The threshold at which drugs ...

BETHESDA, Md. — (NMRC)’s Clinical Trials Center (CTC) is seeking volunteers to participate in a phase 1 clinical trial for a vaccine aimed at reducing frequency ...